After spending years and hundreds of millions of dollars, Johnson and Johnson has won FDA approval for its new surgical robot Ottava. Can it challenge the dominance of competitors who entered the race years earlier, or is the market already spoken for? (Source: Bloomberg)
After spending years and hundreds of millions of dollars, Johnson and Johnson has won FDA approval for its new surgical robot Ottava. Can it challenge the dominance of competitors who entered the race years earlier, or is the market already spoken for? (Source: Bloomberg)
<iframe src="https://statesidedaily.com/embed/cluster/a0081c3b8373eefc4f8b0e742afd74b9ce3d862d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="This Surgical Robot Could Transform the Operating Room"></iframe>
